Iridex Q2 EPS $(0.17) Misses $(0.11) Estimate, Sales $12.86M Miss $14.23M Estimate
Portfolio Pulse from bharat@benzinga.com
Iridex reported Q2 losses of $0.17 per share, missing the analyst consensus estimate of $0.11 by 54.55%. This is a 21.43% decrease from the same period last year. The company also reported quarterly sales of $12.86 million, missing the analyst consensus estimate of $14.23 million by 9.66%. This is a 6.54% decrease from the same period last year.
August 10, 2023 | 8:17 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Iridex's Q2 earnings and sales missed analyst estimates, indicating a potential negative impact on the company's stock.
Iridex's Q2 earnings and sales fell short of analyst estimates, which could lead to a decrease in investor confidence and a potential drop in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100